Replies to post #214317 on Biotech Values

[DewDiligence]

AST +46% on pump piece:

https://finance.yahoo.com/news/kind-shareholders-own-asterias-biotherapeutics-133233537.html

[DewDiligence]

BTX acquires AST in all-stock deal worth $1.49/sh (at yesterday’s BTX closing price of $2.10)—a 41% premium to AST’s close yesterday—but a step discount to AST’s most recent financing (#msg-135432050).

https://www.businesswire.com/news/home/20181108005314/en

The nominal deal value is $85M.